Anti-YTHDF1 antibody [R04-1R-3] (STJA0033048)

SKU:
STJA0033048
£214.50 - £308.50
Free Shipping
Processing The item has been added

Host: Mouse
Applications: WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description : Mouse monoclonal anti-YTHDF1 for use in WB in Human samples. Datasheet included with dilution recommendations, and related reagents.
Clonality : Monoclonal
Clone ID : R04-1R-3
Conjugation: Unconjugated
Isotype: IgG1k
Formulation: Liquid in PBS, Glycerol and BSA
Purification: Protein G
Dilution Range: WB 1:500-1:1000
Storage Instruction: Store at-20°C. Avoid freeze/thaw cycles.
Gene Symbol: YTHDF1
Gene ID: 54915
Uniprot ID: YTHD1_HUMAN
Immunogen: Peptide
Post Translational Modifications Ubiquitinated by the CUL7-FBXW8 E3 ligase complex leading to degradation. Deubiquitinated and stabilized by USP5 by removing 'Lys-11'-linked polyubiquitination.
Function Specifically recognizes and binds N6-methyladenosine (m6A)-containing mRNAs, and regulates their stability. M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing. Acts as a regulator of mRNA stability by promoting degradation of m6A-containing mRNAs via interaction with the CCR4-NOT complex. The YTHDF paralogs (YTHDF1, YTHDF2 and YTHDF3) shares m6A-containing mRNAs targets and act redundantly to mediate mRNA degradation and cellular differentiation. Required to facilitate learning and memory formation in the hippocampus by binding to m6A-containing neuronal mRNAs. Acts as a regulator of axon guidance by binding to m6A-containing ROBO3 transcripts. Acts as a negative regulator of antigen cross-presentation in myeloid dendritic cells. In the context of tumorigenesis, negative regulation of antigen cross-presentation limits the anti-tumor response by reducing efficiency of tumor-antigen cross-presentation. Promotes formation of phase-separated membraneless compartments, such as P-bodies or stress granules, by undergoing liquid-liquid phase separation upon binding to mRNAs containing multiple m6A-modified residues: polymethylated mRNAs act as a multivalent scaffold for the binding of YTHDF proteins, juxtaposing their disordered regions and thereby leading to phase separation. The resulting mRNA-YTHDF complexes then partition into different endogenous phase-separated membraneless compartments, such as P-bodies, stress granules or neuronal RNA granules.
Protein Name Yth Domain-Containing Family Protein 1
Df1
Dermatomyositis Associated With Cancer Putative Autoantigen 1
Daca-1
Database Links
Cellular Localisation Cytoplasm
P-Body
Stress Granule
Alternative Antibody Names Anti-Yth Domain-Containing Family Protein 1 antibody
Anti-Df1 antibody
Anti-Dermatomyositis Associated With Cancer Putative Autoantigen 1 antibody
Anti-Daca-1 antibody
Anti-YTHDF1 antibody
Anti-C20orf21 antibody

Information sourced from Uniprot.org